MIRA Pharmaceuticals (NASDAQ:MIRA) | WebDisclosure

Basculer en Français

11314	Companies
251411	Keywords
180504	Articles
137247	Press releases

Home
Companies
MIRA Pharmaceuticals

PRESS RELEASE

published on 07/22/2024 at 14:00, 2 years 3 months ago

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
MIRA Pharmaceuticals reveals new promising preclinical data for Ketamir-2, a novel oral ketamine analog, indicating potential advantages for treating neurological and neuropsychiatric disorders

Preclinical Study Neurological Disorders MIRA Pharmaceuticals Neuropsychiatric Disorders Ketamir-2
BRIEF

published on 07/15/2024 at 13:05, 2 years 3 months ago

Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC

Pharmaceuticals Preclinical Studies MIRA-55 Anxiety Treatment THC Comparison
BRIEF

published on 07/15/2024 at 13:05, 2 years 3 months ago

Mira Pharmaceuticals annonce des résultats prometteurs pour MIRA-55 dans plusieurs tests précliniques par rapport au THC

Médicaments Etudes Précliniques MIRA-55 Traitement De L'anxiété Comparaison Du THC
PRESS RELEASE

published on 07/15/2024 at 13:00, 2 years 3 months ago

Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
MIRA Pharmaceuticals, Inc. confirms promising findings on new oral pharmaceutical marijuana analog, MIRA-55, as a potential treatment for neurological and neuropsychiatric disorders. Comparison to THC shows enhanced efficacy and consistent anxiolytic effects

Neurological Disorders Preclinical Studies MIRA-55 MIRA Pharmaceuticals Neuropsychiatric Disorders

Accesswire

Published on 11/11/2026 at 00:40, 1 hour 36 minutes ago

Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 2 hours 46 minutes ago

CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 3 hours 16 minutes ago

Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 3 hours 16 minutes ago

Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 3 hours 16 minutes ago

Condor Agrees to Short Extension of Lucero Closing Payment with ELEMENT79 and Provides Huiñac Punta Drill Program Update

View all ACCESSWIRE

EQS Group

Published on 11/11/2026 at 00:15, 2 hours 1 minute ago

Lean Focus Launches Asia Pacific: Local Expertise. Global Impact.
Published on 11/10/2026 at 23:15, 3 hours 1 minute ago

GSMA MWC26 Doha welcomed over 10,000 attendees, as world-first ITU co-location puts MENA at the centre of global connectivity policy and innovation
Published on 11/10/2026 at 21:24, 4 hours 52 minutes ago

EQS-Adhoc: Kapsch TrafficCom AG:
Published on 11/10/2026 at 21:18, 4 hours 58 minutes ago

ARYZTA director steps down
Published on 11/10/2026 at 19:21, 6 hours 55 minutes ago

ALTHEORA, Mäder Composites France et IPC s'associent pour donner une seconde vie aux matériaux composites

Les Echos

Published on 11/10/2026 at 18:00, 8 hours 16 minutes ago

Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 8 hours 31 minutes ago

Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:40, 8 hours 36 minutes ago

Production du 3ième trimestre 2026
Published on 11/10/2026 at 17:35, 8 hours 41 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 8 hours 44 minutes ago

CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.

View all LES ECHOS COMFI WIRE